Xiang, Yufei

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?

Liu, B., Li, M., Zhou, Z., Guan, X., & Xiang, Y. (2020) · Journal of Autoimmunity

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 763

Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)

Zhou, Z., Xiang, Y., Ji, L., Jia, W., Ning, G., Huang, G., Yang, L., Lin, J., Liu, Z., Hagopian, W. A., et al. (2013) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 251

Past, present and future of latent autoimmune diabetes in adults

Liu, B., Xiang, Y., Liu, Z., & Zhou, Z. (2020) · Diabetes/Metabolism Research and Reviews

Diabetes and associated disordersDiabetes Management and Research

Cited by 50

Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5

Xiang, Y., Huang, G., Shan, Z., Pan, L., Luo, S., Yang, L., Shi, L., Li, Q., Leslie, R. D., & Zhou, Z. (2015) · Acta Diabetologica

Diabetes and associated disordersDiabetes Management and Research

Cited by 42

Combination therapy with saxagliptin and vitamin D for the preservation of β-cell function in adult-onset type 1 diabetes: a multi-center, randomized, controlled trial

Yan, X., Li, X., Liu, B., Huang, J., Xiang, Y., Hu, Y., Tang, X., Zhang, Z., Huang, G., Xie, Z., et al. (2023) · Signal Transduction and Targeted Therapy

Diabetes and associated disordersDiabetes Treatment and Management

Cited by 28